Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
Alternativ können Sie versuchen, selbst über Ihren lokalen Bibliothekskatalog auf das gewünschte Dokument zuzugreifen.
Bei Zugriffsproblemen kontaktieren Sie uns gern.
125 Ergebnisse
Sortierung:
In: Defence science journal: DSJ, Band 38, Heft 2, S. 197-201
ISSN: 0011-748X
In: Defence science journal: DSJ, Band 35, Heft 4, S. 425-429
ISSN: 0011-748X
Epistaxis, being the commonest ENT emergency requiring hospital admission, is clearly an important condition — not only to the specialist but also to any general practitioner. The role of routine coagulation studies in the management of patients suffering from epistaxis is unclear. In an attempt to address this issue, the prospective case study was carried out in the department of ENT in Government medical college and hospital Nagpur over span of 2 years from October 2001 to November 2003 in which 100 cases were studied. Coagulation studies were carried out in 100 patients but only 7 patients had abnormal coagulation profile. No other coagulation abnormalities were identified. This study supports the view that there does not appear to br role for routine coagulation studies in patients of epistaxis. The investigation for potential haemostatic disorder should be performed when clinically indicated and if necessary, in consultation with the hematology service.
BASE
A typology of organizational arrangements between state and local public health agencies was used as a framework within which the organizational environment of the local health department was studied for its effects on program development and implementation by local public health departments. Data collected in a national sample of local health officers were used in measuring the effect of four different patterns of administrative relationships on the selected characteristics of local health department programs. Important differences were observed among the four organizational types with regard to constraints on programs and program priorities, and health officers' perceptions of the primary functions of local health departments and sources of local health department funding. These findings were then used as a baseline from which to consider the possible impact of recent federal health budgetary proposals (specifically, block grants) both on existing patterns of intergovernmental relations and on the funding and operation of local health department programs. It was determined that the most likely general development arising from these proposed changes in federal budgetary policy is that the administrative control of state health agencies over those at the local level is likely to be enhanced. Other likely developments include changes in the programs and priorities of local health departments related to reductions in overall funding levels for human services and forced competition for fewer dollars by an enlarged constituency.
BASE
Bangladesh has made significant progress towards elimination of visceral leishmaniasis, and is on track to achieve its target of less than one case per 10,000 inhabitants in each subdistrict in 2017. As the incidence of disease falls, it is likely that the political capital and financial resources dedicated towards the elimination of visceral leishmaniasis may decrease, raising the prospect of disease resurgence. Policy memos may play a crucial role during the transition of the elimination plan from the 'attack' to the 'consolidation' and 'maintenance' phases, highlighting key stakeholders and areas where ongoing investment is crucial. An example of a policy brief is outlined in this paper. The background to the current elimination efforts is highlighted, with emphasis on remaining uncertainties including the impact of disease reservoirs and sustainable surveillance strategies. A stakeholder map is provided outlining the current and projected future activities of key bodies. Identification of key stakeholders subsequently frames the discussion of three key policy recommendations in the Bangladeshi context for the transition to the consolidation and maintenance phases of the elimination program. Recommendations include determining optimal vector control and surveillance strategies, shifting the emphasis towards horizontal integration of disease programs, and prioritising remaining research questions with a focus on operational and technical capacity. Achieving elimination is as much a political as a scientific question. Integrating the discussion of key stakeholders with policy priorities and the research agenda provides a novel insight into potential pathways forwards in the elimination of visceral leishmaniasis in Bangladesh and in the rest of the Indian subcontinent.
BASE
In: Transcultural psychiatry, Band 60, Heft 3, S. 602-609
ISSN: 1461-7471
The field of Global Mental Health (GMH) aims to address the global burden of mental illness by focusing on closing the "treatment gap" faced by many low- and middle-income countries (LMICs). To increase access to services, GMH prioritizes "scaling up" mental health services, primarily advocating for the export of Western centred and developed biomedical and psychosocial "evidence-based" approaches to the Global South. While this emphasis on scalability has resulted in the increased availability of mental health services in some LMICs, there have been few critical discussions of this strategy. This commentary critically appraises the scalability of GMH by questioning the validity and sustainability of its approach. We argue that the current approach emphasizes the development of mental health services and interventions in "silos," focusing on the treatment of mental illnesses at the exclusion of a holistic and contextualized approach to people's needs. We also question the opportunities that the current approach to GMH offers for the growth of mental health programmes of local NGOs and investigate the potential pitfalls that scalability may have on NGOs' impact and ability to innovate. This commentary argues that any "scaling up" of mental health services must place sustainability at the core of its mission by favouring the growth and development of local solutions and wider forms of support that prioritize social inclusion and long-lasting mental health recovery.
In: Sociological bulletin: journal of the Indian Sociological Society, Band 20, Heft 2, S. 207-231
ISSN: 2457-0257
In: Biopolitics 18
Frontmatter -- Contents -- Acknowledgments -- 1. Introduction: Why "Against Health"? -- Part I : What Is Health, Anyway? -- 2. What Is Health and How Do You Get It? -- 3 Risky Bigness: On Obesity, Eating, and the Ambiguity of "Health" -- 4 Against Global Health? Arbitrating Science, Non-Science, and Nonsense through Health -- Part II : Seeing Health through Morality -- 5 The Social Immorality of Health in the Gene Age: Race, Disability, and Inequality -- 6. Fat Panic and the New Morality -- 7 Against Breastfeeding (Sometimes) -- Part III : Making Health and Disease -- 8 Pharmaceutical Propaganda -- 9 The Strangely Passive-Aggressive History of Passive-Aggressive Personality Disorder -- 10 Obsession: Against Mental Health -- 11 Atomic Health, or How The Bomb Altered American Notions of Death -- Part IV : Pleasure and Pain after Health -- 12 How Much Sex Is Healthy? The Pleasures of Asexuality -- 13 Be Prepared -- 14 In the Name of Pain -- 15 Conclusion: What Next? -- About the Contributors -- Index
Frontmatter --Contents --Notes on Contributors --Introduction: The Political Landscapes of American Health, 1945-2020 --Part I: Geography, Community and American Health --Introduction --1 Health and Inequality in the Postwar Metropolis --2 Poverty, Health and Health Care in Rural Communities --3 The Politics of Immigration Meets the Politics of Health Care --4 Latinxs and the US Health Care System --5 American Indian Health: The Medicine Wheel versus the Iron Triangle --Part II: Critical Health Conditions: Debates and Histories --Introduction --6 The Politics of Polio Vaccination in Postwar America, 1950-60: Detractors and Defenders --7 Beyond the Cancer Wars --8 A System in Crisis: US Health Care Politics and the AIDS Epidemic --9 The Politics of 'Obesity': Medicalization, Stigmatization and Liberation of Fat Bodies --10 Revising Diagnoses, Reinventing Psychiatry: DSM and Major Depressive Disorder --Part III: The Politics of Children's Health --Introduction --11 US Children's Health Insurance: Policy Advocacy and Ideological Conflict --12 Autism and the Anti-Vaccine Movement --13 Diagnosing Deficit, Promising Enhancement: ADHD and Stimulants on Screen --14 On the Possibility of Affirmative Health Care for Transgender Children --15 Black Infant Mortality: Continuities, Contestations and Care --Part IV: The Institutional Matrix of Health Care --Introduction --16 The Regional and Racial Politics of Postwar Hospitals --17 Health Activism in the 1960s and the Community Health Center System --18 The Veterans Administration and PTSD: Challenges and Changes from Vietnam to Iraq --19 The Pharmaceutical Industry, Drug Regulation and US Health Services --20 The National Institutes of Health: Courting Congress, Creating a Research Infrastructure --Part V: The White House, Congress and Health Reform --Introduction --21 Left Out: Health Security and the American Welfare State, 1935-50 --22 Medicare and Medicaid after the Great Society: Containing Costs, Expanding Coverage --23 Mental Health, Stigma and Federal Reform in the 1970s and 1990s --24 The War on Drugs: Nixon, Reagan, Trump --25 Obamacare and Its Critics --Part VI: Justice, Ethics and American Health --Introduction --26 Roe v. Wade and the Cultural Politics of Abortion: The Shift from Rights to Health --27 Genetics, Health and the Making of America's Triracial Isolates, 1950-80 --28 The Rhetoric and Politics of American Ageism: Notes from a Pandemic --29 Towards a Structural Competency Framework for Addressing US Gun Violence --30 Mass Incarceration and Health Inequity in the United States --Part VII: Public Health and Global Health --Introduction --31 Occupational and Environmental Health in Twentieth-Century America --32 Environmental Health beyond the State: Thinking through the 1970s --33 Bioterrorism, Pandemic and the American Public --34 Health Internationalism in the US and Beyond --35 Pandemics and the Politics of Planetary Health --Bibliography --Index
Examines the diverse, and often conflicted, political status of health in the United States from World War II to Covid-19Explores the histories, cultures, policies and technologies of American health and medicine as they have developed over a 75-year periodBrings together 45 experts from the US, Canada and the UK working across the fields of medicine, health policy, political and social history, political science, environmental studies, law, and cultural studiesUses the lenses of class, poverty, race, gender, sexuality and locality to study the concepts, policies and lived realities of U.S. healthcare and medical treatmentExplores key controversies in American health, including global health and new technologiesBy emphasising the plurality of health experiences, and balancing national and transnational perspectives with the lived realities of diverse communities, this groundbreaking collection expands far beyond biomedical conceptions of health. Together, the contributors take a multi-layered view of the politics of US healthcare by examining it from historical, cultural, medical, sociological, legal, ethical and environmental perspectives. Chapters consider major health institutions and the federal policies that guide them; the intersection between health and social movements; the contours of health and illness with respect to race, gender, sexuality, age and region; and the US's often-conflicted role in global health governance
FMSR (Austria) ; FNRS (Belgium) ; FWO (Belgium) ; Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) ; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) ; Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) ; Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) ; MES (Bulgaria) ; CERN (China) ; CAS (China) ; MoST (China) ; NSFC (China) ; COLCIENCIAS (Colombia) ; MSES (Croatia) ; RPF (Cyprus) ; Academy of Sciences and NICPB (Estonia) ; Academy of Finland, ME, and HIP (Finland) ; CEA (France) ; CNRS/IN2P3 (France) ; BMBF (Germany) ; DFG (Germany) ; HGF (Germany) ; GSRT (Greece) ; OTKA (Hungary) ; NKTH (Hungary) ; DAE (India) ; DST (India) ; IPM (Iran) ; SFI (Ireland) ; INFN (Italy) ; NRF (Korea) ; LAS (Lithuania) ; CINVESTAV (Mexico) ; CONACYT (Mexico) ; SEP (Mexico) ; UASLP-FAI (Mexico) ; PAEC (Pakistan) ; SCSR (Poland) ; FCT (Portugal) ; JINR (Armenia, Belarus, Georgia, Ukraine, Uzbekistan) ; MST (Russia) ; MAE (Russia) ; MSTDS (Serbia) ; MICINN ; CPAN (Spain) ; Swiss Funding Agencies (Switzerland) ; NSC (Taipei) ; TUBITAK ; TAEK (Turkey) ; STFC (United Kingdom) ; DOE (USA) ; NSF (USA) ; European Union ; Leventis Foundation ; A. P. Sloan Foundation ; Alexander von Humboldt Foundation ; Measurements of inclusive charged-hadron transverse-momentum and pseudorapidity distributions are presented for proton-proton collisions at root s = 0.9 and 2.36 TeV. The data were collected with the CMS detector during the LHC commissioning in December 2009. For non-single-diffractive interactions, the average charged-hadron transverse momentum is measured to be 0.46 +/- 0.01 (stat.) +/- 0.01 (syst.) GeV/c at 0.9 TeV and 0.50 +/- 0.01 (stat.) +/- 0.01 (syst.) GeV/c at 2.36 TeV, for pseudorapidities between -2.4 and +2.4. At these energies, the measured pseudorapidity densities in the central region, dN(ch)/d eta vertical bar(vertical bar eta vertical bar and pp collisions. The results at 2.36 TeV represent the highest-energy measurements at a particle collider to date.
BASE
Individuals have received support from the Marie-Curie program and the European Research Council and EPLANET (European Union); the Leventis Foundation; the Alfred P. Sloan Foundation; the Alexander von Humboldt Foundation; the Belgian Federal Science Policy Office; the Fonds pour la Formation à la Recherche dans l'Industrie et dans l'Agriculture (FRIA-Belgium); the Agentschap voor Innovatie door Wetenschap en Technologie (IWT-Belgium); the Ministry of Education, Youth and Sports (MEYS) of the Czech Republic; the Council of Science and Industrial Research, India; the HOMING PLUS program of the Foundation for Polish Science, cofinanced from European Union, Regional Development Fund, the Mobility Plus program of the Ministry of Science and Higher Education, the National Science Center (Poland), contracts Harmonia 2014/14/M/ST2/00428, Opus 2013/11/B/ST2/04202, 2014/13/B/ST2/02543 and 2014/15/B/ST2/03998, Sonata-bis 2012/07/E/ST2/01406; the Thalis and Aristeia programs cofinanced by EU-ESF and the Greek NSRF; the National Priorities Research Program by Qatar National Research Fund; the Programa Clarín-COFUND del Principado de Asturias; the Rachadapisek Sompot Fund for Postdoctoral Fellowship, Chulalongkorn University and the Chulalongkorn Academic into Its 2nd Century Project Advancement Project (Thailand); and the Welch Foundation, contract C-1845.
BASE
© 2017 CERN, for the CMS Collaboration. Differential and double-differential cross sections for the production of top quark pairs in proton-proton collisions at 13 TeV are measured as a function of jet multiplicity and of kinematic variables of the top quarks and the top quark-antiquark system. This analysis is based on data collected by the CMS experiment at the LHC corresponding to an integrated luminosity of 2.3 fb−1. The measurements are performed in the lepton+jets decay channels with a single muon or electron in the final state. The differential cross sections are presented at particle level, within a phase space close to the experimental acceptance, and at parton level in the full phase space. The results are compared to several standard model predictions. ; we acknowledge the enduring support for the construction and operation of the LHC and the CMS detector provided by the following funding agencies: the Austrian Federal Ministry of Science, Research and Economy and the Austrian Science Fund; the Belgian Fonds de la Recherche Scientifique, and Fonds voor Wetenschappelijk Onderzoek; the Brazilian Funding Agencies (CNPq, CAPES, FAPERJ, and FAPESP); the Bulgarian Ministry of Education and Science; CERN; the Chinese Academy of Sciences, Ministry of Science and Technology, and National Natural Science Foundation of China; the Colombian Funding Agency (COLCIENCIAS); the Croatian Ministry of Science, Education and Sport, and the Croatian Science Foundation; the Research Promotion Foundation, Cyprus; the Secretariat for Higher Education, Science, Technology, and Innovation, Ecuador; the Ministry of Education and Research, Estonian Research Council via Grants No. IUT23-4 and No. IUT23-6 and European Regional Development Fund, Estonia; the Academy of Finland, Finnish Ministry of Education and Culture, and Helsinki Institute of Physics; the Institut National de Physique Nucléaire et de Physique des Particules/CNRS, and Commissariat à l'Énergie Atomique et aux Énergies Alternatives/CEA, France; the Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft, and Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany; the General Secretariat for Research and Technology, Greece; the National Scientific Research Foundation, and National Innovation Office, Hungary; the Department of Atomic Energy and the Department of Science and Technology, India; the Institute for Studies in Theoretical Physics and Mathematics, Iran; the Science Foundation, Ireland; the Istituto Nazionale di Fisica Nucleare, Italy; the Ministry of Science, ICT, and Future Planning, and National Research Foundation (NRF), Republic of Korea; the Lithuanian Academy of Sciences; the Ministry of Education, and University of Malaya (Malaysia); the Mexican Funding Agencies (BUAP, CINVESTAV, CONACYT, LNS, SEP, and UASLP-FAI); the Ministry of Business, Innovation and Employment, New Zealand; the Pakistan Atomic Energy Commission; the Ministry of Science and Higher Education and the National Science Centre, Poland; the Fundação para a Ciência e a Tecnologia, Portugal; JINR, Dubna; the Ministry of Education and Science of the Russian Federation, the Federal Agency of Atomic Energy of the Russian Federation, Russian Academy of Sciences, and the Russian Foundation for Basic Research; the Ministry of Education, Science and Technological Development of Serbia; the Secretaría de Estado de Investigación, Desarrollo e Innovación and Programa Consolider-Ingenio 2010, Spain; the Swiss Funding Agencies (ETH Board, ETH Zurich, PSI, SNF, UniZH, Canton Zurich, and SER); the Ministry of Science and Technology, Taipei; the Thailand Center of Excellence in Physics, the Institute for the Promotion of Teaching Science and Technology of Thailand, Special Task Force for Activating Research and the National Science and Technology Development Agency of Thailand; the Scientific and Technical Research Council of Turkey, and Turkish Atomic Energy Authority; the National Academy of Sciences of Ukraine, and State Fund for Fundamental Researches, Ukraine; the Science and Technology Facilities Council, United Kingdom; the U.S. Department of Energy, and the U.S. National Science Foundation. Individuals have received support from the Marie-Curie program and the European Research Council and EPLANET (European Union); the Leventis Foundation; the A. P. Sloan Foundation; the Alexander von Humboldt Foundation; the Belgian Federal Science Policy Office; the Fonds pour la Formation à la Recherche dans l'Industrie et dans l'Agriculture (FRIA-Belgium); the Agentschap voor Innovatie door Wetenschap en Technologie (IWTBelgium); the Ministry of Education, Youth and Sports (MEYS) of the Czech Republic; the Council of Science and Industrial Research, India; the HOMING PLUS program of the Foundation for Polish Science, cofinanced by the European Union, Regional Development Fund, the Mobility Plus program of the Ministry of Science and Higher Education, the National Science Center (Poland), Contracts No. Harmonia 2014/14/M/ST2/00428, No. Opus 2013/11/B/ST2/04202, No. 2014/13/B/ST2/02543, and No. 2014/15/B/ST2/03998, and Sonata-bis Contract No. 2012/07/E/ST2/01406; the Thalis and Aristeia programs cofinanced by EU-ESF and the Greek NSRF; the National Priorities Research Program by Qatar National Research Fund; the Programa Clarín-COFUND del Principado de Asturias; the Rachadapisek Sompot Fund for Postdoctoral Fellowship, Chulalongkorn University and the Chulalongkorn Academic into its 2nd Century Project Advancement Project (Thailand); and the Welch Foundation, Contract No. C-1845.
BASE
BMWFW (Austria) ; FWF (Austria) ; FNRS (Belgium) ; FWO (Belgium) ; Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) ; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) ; Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) ; Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) ; MES (Bulgaria) ; CERN ; CAS (China) ; MOST (China) ; NSFC (China) ; COLCIENCIAS (Colombia) ; MSES (Croatia) ; CSF (Croatia) ; RPF (Cyprus) ; SENESCYT (Ecuador) ; MoER (Estonia) ; ERC IUT (Estonia) ; ERDF (Estonia) ; Academy of Finland (Finland) ; MEC (Finland) ; HIP (Finland) ; CEA (France) ; CNRS/IN2P3 (France) ; BMBF (Germany) ; DFG (Germany) ; HGF (Germany) ; GSRT (Greece) ; OTKA (Hungary) ; NIH (Hungary) ; DAE (India) ; DST (India) ; IPM (Iran) ; SFI (Ireland) ; INFN (Italy) ; MSIP (Republic of Korea) ; NRF (Republic of Korea) ; LAS (Lithuania) ; MOE (Malaysia) ; UM (Malaysia) ; BUAP (Mexico) ; CINVESTAV (Mexico) ; CONACYT (Mexico) ; LNS (Mexico) ; SEP (Mexico) ; UASLP-FAI (Mexico) ; MBIE (New Zealand) ; PAEC (Pakistan) ; MSHE (Poland) ; NSC (Poland) ; FCT (Portugal) ; JINR (Dubna) ; MON (Russia) ; RosAtom (Russia) ; RAS (Russia) ; RFBR (Russia) ; MESTD (Serbia) ; SEIDI (Spain) ; CPAN (Spain) ; Swiss Funding Agencies (Switzerland) ; MST (Taipei) ; ThEPCenter (Thailand) ; IPST (Thailand) ; STAR (Thailand) ; NSTDA (Thailand) ; TUBITAK (Turkey) ; TAEK (Turkey) ; NASU (Ukraine) ; SFFR (Ukraine) ; STFC (United Kingdom) ; DOE (USA) ; NSF (USA) ; Marie-Curie programme ; European Research Council (European Union) ; Leventis Foundation ; A. P. Sloan Foundation ; Alexander von Humboldt Foundation ; Belgian Federal Science Policy Office ; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA-Belgium) ; Agentschap voor Innovatie door Wetenschap en Technologie (IWT-Belgium) ; Ministry of Education, Youth and Sports (MEYS) of the Czech Republic ; Council of Science and Industrial Research, India ; HOMING PLUS programme of the Foundation for Polish Science ; European Union, Regional Development Fund ; Mobility Plus programme of the Ministry of Science and Higher Education ; National Science Center (Poland) ; Thalis programme - EU-ESF ; Aristeia programme - EU-ESF ; Greek NSRF ; National Priorities Research Program by Qatar National Research Fund ; Programa Clarin-COFUND del Principado de Asturias ; Rachadapisek Sompot Fund for Postdoctoral Fellowship (Thailand) ; Chulalongkorn University (Thailand) ; Chulalongkorn Academic into Its 2nd Century Project Advancement Project (Thailand) ; Welch Foundation ; EPLANET (European Union) ; National Science Center (Poland): Harmonia 2014/14/M/ST2/00428 ; National Science Center (Poland): Opus 2013/11/B/ST2/04202 ; National Science Center (Poland): 2014/13/B/ST2/02543 ; National Science Center (Poland): 2014/15/B/ST2/ 03998 ; National Science Center (Poland): Sonata-bis 2012/07/E/ST2/01406 ; Welch Foundation: C-1845 ; The invariance of the standard model (SM) under the CPT transformation predicts equality of particle and antiparticle masses. This prediction is tested by measuring the mass difference between the top quark and antiquark (Delta m(t) = m(t) - m((t) over bar)) that are produced in pp collisions at a center-of-mass energy of 8 TeV, using events with a muon or an electron and at least four jets in the final state. The analysis is based on data corresponding to an integrated luminosity of 19.6 fb(-1) collected by the CMS experiment at the LHC, and yields a value of Delta m(t) = 0.15 0.19 (stat) +/- 0.09(syst) GeV, which is consistent with the SM expectation. This result is significantly more precise than previously reported measurements. (C) 2017 The Author(s). Published by Elsevier B.V.
BASE